SUANFARMA is joining forces with Reyoung Pharmaceutical, for anti-infective and antibacterial API production. The technology developed by SUANFARMA involves flow chemistry, improving yields, selectivity, and reproducibility of the processes. It minimizes reaction times and requires smaller quantities of reagents and solvents, reducing raw material use and environmental impact. In addition, this technique is generally safer than traditional synthesis, reducing the risk of explosions and leaks of ...